| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/25/2007 | WO2006121610A3 Personal care compositions and methods for their use |
| 01/25/2007 | WO2006031607A3 A method of treating cancer |
| 01/25/2007 | WO2005118527A3 Fluorous capping reagents, and methods for peptide purification |
| 01/25/2007 | WO2004063337A3 Kunitz domain library |
| 01/25/2007 | US20070021350 Conjugates useful in the treatment of prostate cancer |
| 01/25/2007 | US20070021349 Orthogonally protected bifunctional amino acid |
| 01/25/2007 | US20070021348 Novel treatment |
| 01/25/2007 | US20070021346 N-terminally modified GLP-1 receptor modulators |
| 01/25/2007 | US20070020733 Polypeptide for use in the diagnosis and detection of bacterial infections |
| 01/25/2007 | US20070020695 Immunogenic peptide sequences; antibodies directed against particular amino acid regions of Hsp70B' |
| 01/25/2007 | US20070020678 Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides |
| 01/25/2007 | US20070020344 inhibition and/or prevention of on-growth of biological organisms on objects or living beings, includes at least one cyclotide, and a suitable carrier medium |
| 01/25/2007 | DE10163333B4 Modifizierte Tridegine, ihre Herstellung deren Verwendung als Transglutaminase Inhibitoren und diese enthaltende Arzneimittel und Kombinationspräparate Modified Tridegine, their preparation and their use as medicaments containing transglutaminase inhibitors and compounds |
| 01/25/2007 | CA2658491A1 Membrane-translocating peptides |
| 01/25/2007 | CA2616583A1 Peptides for use in the treatment of obesity |
| 01/25/2007 | CA2614811A1 Process for the manufacture of eptifibatide |
| 01/24/2007 | EP1745071A2 Msh-agonist tripeptide conjugates |
| 01/24/2007 | EP1745065A1 Antimicrobial polypeptides |
| 01/24/2007 | EP1664080A4 Peptide-based diblock and triblock dispersants and diblock polymers |
| 01/24/2007 | EP1481007B1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, treatments and animal models produced therefrom |
| 01/24/2007 | EP1390405B1 Preparation of cholecystokinin agonists and antagonists and their therapeutic and diagnostic use |
| 01/24/2007 | EP0973799B1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 01/24/2007 | EP0941244B1 Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide and a method of detecting auto-immune antibodies |
| 01/24/2007 | CN1902313A Wt1-origin HLA-DR-binding antigen peptide |
| 01/24/2007 | CN1902217A Novel peptide, process for producing the same and pharmaceutical composition containing the peptide |
| 01/24/2007 | CN1900110A Octreotide allosteric peptide molecule and its medicine |
| 01/24/2007 | CN1900109A Amolops loloensis insulin release promoting peptide and use in producing medicine |
| 01/24/2007 | CN1900108A Chronic myelogenous leukemia cell KT-1/A3 specific targeting short peptide series and its sieving |
| 01/24/2007 | CN1899613A Therapeutic polypeptide hepatitis B vaccine and its preparing method and using method |
| 01/24/2007 | CN1899612A Therapeutical peptide hepatitis C vaccine and its preparing method |
| 01/24/2007 | CN1899611A Therapeutical polypeptide hepatitis B vaccine and its preparing method |
| 01/24/2007 | CN1296384C Peptide having preptin functionality |
| 01/24/2007 | CN1296381C VEGF peptides and their use for inhibiting angiogenesis |
| 01/23/2007 | US7166695 Affinity markers for human serum albumin |
| 01/23/2007 | US7166694 Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells |
| 01/23/2007 | US7166692 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 01/23/2007 | US7166572 12-benzyloxy-23-((1S)-2-benzyloxy-1-hydroxy-2-(4-hydroxyphenyl)ethyl)-2,11,15-trihydrox6-((1R)-1-hydroxy-ethyl)-20-hydroxymethyl-16-16]hexaazacyclohenicosin-9-yl]-12-methyltetradecanamide; echinocandin class with a substituent at the ornithine-5, homotyrosine-4 and ortho position; fungal infections |
| 01/23/2007 | US7166436 Compound for use as diagnostic tool in protein analysis |
| 01/23/2007 | CA2208928C Selective stabilization of protein during viral inactivation |
| 01/23/2007 | CA2141106C Glycopeptide antibiotic derivatives |
| 01/18/2007 | WO2007008684A2 Ligands of melanocortin receptors |
| 01/18/2007 | WO2007006548A2 Antibacterial amide macrocycles vii |
| 01/18/2007 | WO2006107183A8 Mussel bioadhesive |
| 01/18/2007 | WO2006094193A3 Compositions and methods for topical application and transdermal delivery of an oligopeptide |
| 01/18/2007 | WO2006094082A3 Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity |
| 01/18/2007 | WO2006083317A3 Peptide antibiotics and methods for making same |
| 01/18/2007 | WO2006072048A3 Compositions and methods for identifying modulators of hausp |
| 01/18/2007 | WO2006031117A8 Lipoxygenase inhibitor peptides and their use |
| 01/18/2007 | US20070015712 Reducing or inhibiting growth or survival of bacteria, viruses and fungi in foods, contact lens and eye wash solutions, and surfaces; oral or injection administration to mammals |
| 01/18/2007 | US20070014813 Immunogenic polypeptide comprising adjuvant (alum); coupled to diphtheria toxoid; diagnosis and treatment |
| 01/18/2007 | US20070014767 TGFbeta1-inhibitor peptides |
| 01/18/2007 | US20070014747 Novel peptidic conjugates for alopecia preventive and curative treatment |
| 01/18/2007 | DE102005032781A1 Antibakterielle Amid-Markozyklen VII Antibacterial amide Marko cycles VII |
| 01/18/2007 | CA2793119A1 Melanocortin receptor ligands |
| 01/18/2007 | CA2614678A1 Ligands of melanocortin receptors |
| 01/17/2007 | EP1742914A1 Cyclobutenedione groups-containing compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 01/17/2007 | EP1742913A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 01/17/2007 | EP1546717A4 Analyzing nerve cell damage |
| 01/17/2007 | EP1301539B1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/17/2007 | EP1223977B1 Modified plant viruses and methods of use thereof |
| 01/17/2007 | EP1087996B1 Glycosulfopeptides and methods of synthesis and use thereof |
| 01/17/2007 | EP1078072B1 New peptide fragments for protein purification |
| 01/17/2007 | EP0220273B2 Synthetic antigens for the detection of aids-related disease |
| 01/17/2007 | CN1897976A Antagonists of the bradykinin b1 receptor |
| 01/17/2007 | CN1897963A Use of cyclic anabaenopeptin-type peptides for the treatment of a condition wherein inhibition of carboxypeptidase u is beneficial, novel anabaenopeptin derivatives and intermediates thereof |
| 01/17/2007 | CN1897962A Glycopegylated erythropoietin |
| 01/17/2007 | CN1897951A Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 01/17/2007 | CN1896099A Zinc finger binding domains for gnn |
| 01/17/2007 | CN1896094A Angiotensin II receptors I immunogenic peptide section and its use |
| 01/17/2007 | CN1895660A Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 01/16/2007 | US7164002 FVIIa antagonists |
| 01/16/2007 | US7163921 Peptide derivatives and medicinal compositions |
| 01/16/2007 | US7163920 Peptide with osteogenic activity |
| 01/16/2007 | US7163802 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 01/16/2007 | US7163695 Histidine copolymer and methods for using same |
| 01/16/2007 | US7163683 Inducing specific B cell anergy to an immunogen comprising a conjugate of a nonimmunogenic valency platform molecule and an analog of the immunogen that (a) binds specifically to B cells to which the immunogen binds and (b) lacks the T cell epitope(s) of the immunogen |
| 01/16/2007 | CA2252055C Fusogenic liposomes |
| 01/16/2007 | CA2232240C Peptide for inhibiting growth of smooth muscle cells |
| 01/11/2007 | WO2007004341A1 Rna-binding peptide |
| 01/11/2007 | WO2007003775A1 Epitopes of the hbsp protein and medical and biotechnological applications thereof, such as for the treatment of chronic hepatitis b |
| 01/11/2007 | WO2006096829A3 Thyrotropin-releasing hormone analogs and method of use |
| 01/11/2007 | WO2006094269A3 Anti-angiogenic compounds |
| 01/11/2007 | WO2006086012A3 Antibiotic compound |
| 01/11/2007 | US20070010656 Novel exendin agonist compounds |
| 01/11/2007 | US20070010655 Stationary phases and a purification process using the stationary phases |
| 01/11/2007 | US20070010455 Serine protease inhibition via 1-{[1-(2-Methoxycarbonylamino-3,3-dimethyl-butyryl)-4-(7-methoxy-2-phenyl-quinolin-4-yloxy)-pyrrolidine-2-carbonyl]-amino}-2-vinyl-cyclopropanecarboxylic acid |
| 01/11/2007 | US20070010452 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 01/11/2007 | US20070010450 Hypertension, salt dependent high blood pressure, hepatic edema and liver cirrhosis; administering a hypotensive, antiedemic, and anticholesterol polypeptide that activates the guanylate cyclase receptor |
| 01/11/2007 | US20070010030 Complement C3 precursor biopolymer markers indicative of insulin resistance |
| 01/11/2007 | US20070009440 Peptide Conjugates and Fluorescence Detection Methods for Intarcellular Caspase Assay |
| 01/11/2007 | DE4342092B4 Langwirkende Injektionssuspension und Verfahren zur Herstellung Long-acting injection suspension and process for producing |
| 01/11/2007 | DE102005031755A1 New peptides that bind to Salmonella, useful for immobilization, detection, concentration and labeling, optionally derivatized with a pharmaceutical |
| 01/11/2007 | CA2650656A1 Cytokine receptor modulators and uses thereof |
| 01/11/2007 | CA2613749A1 Methods and compositions for diagnosis and treatment of viral and bacterial infections |
| 01/10/2007 | EP1742056A2 Determination of a specific immunglobulin using multiple antigens |
| 01/10/2007 | EP1741779A2 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine mediated toxicity |
| 01/10/2007 | EP1741719A1 Epithelial cell growth promoter |
| 01/10/2007 | EP1740614A2 Caspase-2 inhibitors and their biological applications |
| 01/10/2007 | EP1740602A2 A peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5 |
| 01/10/2007 | EP1740601A2 Myosin light chain kinase inhibitors and their use |